Ignacio
Gil Bazo
Investigador hasta 2022
VU University Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de VU University Medical Center (3)
2018
-
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment
Seminars in Cancer Biology, Vol. 52, pp. 259-268
2015
-
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor
Expert Opinion on Investigational Drugs, Vol. 24, Núm. 11, pp. 1493-1500
2014
-
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
Cancer Treatment Reviews, Vol. 40, Núm. 8, pp. 990-1004